Biosensing strategies for the detection of SARS-CoV-2 nucleic acids

J Pharm Biomed Anal. 2023 Aug 5:232:115370. doi: 10.1016/j.jpba.2023.115370. Epub 2023 Mar 29.

Abstract

The COVID-19 pandemic had devastating effects throughout the world, producing a severe crisis in the health systems and in the economy of a long list of countries, even developed ones. Therefore, highly sensitive and selective analytical bioplatforms that allow the descentralized and fast detection of the severe acute respiratory síndrome coronavirus 2 (SARS-CoV-2), are extremely necessary. Since 2020, several reviews have been published, most of them focused on the different strategies to detect the SARS-CoV-2, either from RNA, viral proteins or host antibodies produced due to the presence of the virus. In this review, the most relevant biosensors for the detection of SARS-CoV-2 RNA are particularly addressed, with special emphasis on the discussion of the biorecognition layers and the different schemes for transducing the hybridization event.

Keywords: Biosensing strategies; COVID-19; Genosensor; SARS-CoV-2 RNA detection.

Publication types

  • Review

MeSH terms

  • Biosensing Techniques*
  • COVID-19* / diagnosis
  • Humans
  • Nucleic Acids*
  • Pandemics
  • RNA, Viral / genetics
  • SARS-CoV-2

Substances

  • RNA, Viral
  • Nucleic Acids